Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy.

Zhou T, Watts K, Agalliu I, DiVito J, Hoenig DM.

J Urol. 2013 Oct;190(4):1416-20. doi: 10.1016/j.juro.2013.05.016. Epub 2013 May 14.

PMID:
23685097
2.

Metabolic syndrome and urinary stone composition: what factors matter most?

Kadlec AO, Greco K, Fridirici ZC, Hart ST, Vellos T, Turk TM.

Urology. 2012 Oct;80(4):805-10. doi: 10.1016/j.urology.2012.05.011. Epub 2012 Jul 13.

PMID:
22795374
3.

The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL).

Akman T, Binbay M, Erbin A, Tepeler A, Sari E, Kucuktopcu O, Ozgor F, Muslumanoglu A.

BJU Int. 2012 Dec;110(11 Pt C):E1079-83. doi: 10.1111/j.1464-410X.2012.11548.x. Epub 2012 Oct 9.

4.

Correlation of metabolic syndrome with urinary stone composition.

Cho ST, Jung SI, Myung SC, Kim TH.

Int J Urol. 2013 Feb;20(2):208-13. doi: 10.1111/j.1442-2042.2012.03131.x. Epub 2012 Sep 30.

5.

Changing composition of staghorn calculi.

Viprakasit DP, Sawyer MD, Herrell SD, Miller NL.

J Urol. 2011 Dec;186(6):2285-90. doi: 10.1016/j.juro.2011.07.089. Epub 2011 Oct 20.

PMID:
22014820
6.

Local factors compared with systemic factors in the formation of bladder uric acid stones.

Li WM, Chou YH, Li CC, Liu CC, Huang SP, Wu WJ, Huang CH.

Urol Int. 2009;82(1):48-52. doi: 10.1159/000176025. Epub 2009 Jan 20.

PMID:
19172097
7.

Decreased stone-free rates after percutaneous nephrolithotomy for high calcium phosphate composition kidney stones.

Kacker R, Meeks JJ, Zhao L, Nadler RB.

J Urol. 2008 Sep;180(3):958-60; discussion 960. doi: 10.1016/j.juro.2008.05.031. Epub 2008 Jul 17.

PMID:
18639270
8.

Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.

Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM.

J Urol. 2004 Jul;172(1):159-63.

PMID:
15201761
9.

[Percutaneous nephrolithotomy (PCNL) in subjects over the age of 70: a multicentre retrospective study of 210 cases].

Doré B, Conort P, Irani J, Amiel J, Ferrière JM, Glémain P, Hubert J, Lechevallier E, Meria P, Saussine C, Traxer O; Comité Lithiase de l'Association Française d'Urologie.

Prog Urol. 2004 Dec;14(6):1140-5. French. Erratum in: Prog Urol. 2005 Feb;15(1):V. Amiel, J [added].

PMID:
15751407
10.

Gout, stone composition and urinary stone risk: a matched case comparative study.

Marchini GS, Sarkissian C, Tian D, Gebreselassie S, Monga M.

J Urol. 2013 Apr;189(4):1334-9. doi: 10.1016/j.juro.2012.09.102. Epub 2012 Sep 25.

PMID:
23022002
11.

Computerized Tomography Based Diagnosis of Visceral Obesity and Hepatic Steatosis is Associated with Low Urine pH.

Patel ND, Ward RD, Calle J, Remer EM, Monga M.

J Urol. 2017 Nov;198(5):1085-1090. doi: 10.1016/j.juro.2017.05.079. Epub 2017 Jun 3.

PMID:
28587918
12.

100% uric acid stone formers: what makes them different?

Reichard C, Gill BC, Sarkissian C, De S, Monga M.

Urology. 2015 Feb;85(2):296-8. doi: 10.1016/j.urology.2014.10.029. Epub 2014 Oct 30.

PMID:
25623669
13.

Coexistence of visceral fat and multiple risk factor accumulations is strongly associated with coronary artery disease in Japanese (the VACATION-J study).

Hiuge-Shimizu A, Kishida K, Funahashi T, Okutsu M, Kametani R, Kobayashi H, Nozaki Y, Nomura A, Yokoi H, Yoshizumi T, Ohira T, Nakamura T, Matsuzawa Y, Sumitsuji S, Shimomura I.

J Atheroscler Thromb. 2012;19(7):657-63. Epub 2012 May 4.

14.

The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.

Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K.

Kidney Int. 2004 Feb;65(2):386-92.

15.

Effect of being overweight on urinary metabolic risk factors for kidney stone formation.

Shavit L, Ferraro PM, Johri N, Robertson W, Walsh SB, Moochhala S, Unwin R.

Nephrol Dial Transplant. 2015 Apr;30(4):607-13. doi: 10.1093/ndt/gfu350. Epub 2014 Oct 31.

PMID:
25362001
16.

Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.

Zapolski T, Waciński P, Kondracki B, Rychta E, Buraczyńska MJ, Wysokiński A.

Kardiol Pol. 2011;69(4):319-26.

17.

Kidney stone formation is positively associated with conventional risk factors for coronary heart disease in Japanese men.

Ando R, Nagaya T, Suzuki S, Takahashi H, Kawai M, Okada A, Yasui T, Kubota Y, Umemoto Y, Tozawa K, Kohri K.

J Urol. 2013 Apr;189(4):1340-6. doi: 10.1016/j.juro.2012.11.045. Epub 2012 Nov 14.

PMID:
23159273
18.

Treatment of renal stones in children: a comparison between percutaneous nephrolithotomy and shock wave lithotripsy.

Shokeir AA, Sheir KZ, El-Nahas AR, El-Assmy AM, Eassa W, El-Kappany HA.

J Urol. 2006 Aug;176(2):706-10.

PMID:
16813924
19.

Outcome of percutaneous surgery stratified according to body mass index and kidney stone size.

Sergeyev I, Koi PT, Jacobs SL, Godelman A, Hoenig DM.

Surg Laparosc Endosc Percutan Tech. 2007 Jun;17(3):179-83.

PMID:
17581461
20.

Type 2 diabetes increases the risk for uric acid stones.

Daudon M, Traxer O, Conort P, Lacour B, Jungers P.

J Am Soc Nephrol. 2006 Jul;17(7):2026-33. Epub 2006 Jun 14.

Supplemental Content

Support Center